BioWorld

Sep. 9, 2003

Axon Branches Of Young Mice Push Fast, Retract Within Minutes While Aging Synapses Get Stabler

Incyte's Evolution Continues As It Licenses Late-Stage HIV Drug

Genentech, XOMA Appear Poised For Favorable Word On Raptiva

Other News To Note

Regeneron, Aventis In Potential $485M Alliance On VEGF Trap

Regeneron Inc.'s fortunes - and its stock - experienced an upswing Monday with the disclosure of a potential $485 million deal focused on its VEGF Trap product candidate with Aventis SA. (BioWorld Today) Read More

Biovitrum Lands Blockbuster Deal With Amgen In Metabolics

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

GLP-1s need technologies for long-term use

BioWorld

For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...

UTRN gene involved in arthrogryposis, study finds

BioWorld Science

Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...

HMNC raises $50M series B to prep depression drugs for phase III

BioWorld

HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...